USANA Health Sciences, Inc. (NYSE:USNA) COO Walter Noot Sells 6,291 Shares

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) COO Walter Noot sold 6,291 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $30.29, for a total transaction of $190,554.39. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

USANA Health Sciences Stock Down 0.7%

Shares of USNA traded down $0.20 during trading hours on Friday, reaching $29.97. 184,204 shares of the company traded hands, compared to its average volume of 133,741. The stock has a fifty day simple moving average of $27.39 and a 200 day simple moving average of $31.83. USANA Health Sciences, Inc. has a fifty-two week low of $23.10 and a fifty-two week high of $49.16. The stock has a market capitalization of $558.13 million, a PE ratio of 10.59, a price-to-earnings-growth ratio of 0.93 and a beta of 0.60.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.03. The firm had revenue of $249.54 million for the quarter, compared to the consensus estimate of $243.08 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same quarter in the previous year, the business earned $0.86 EPS. Research analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Institutional Trading of USANA Health Sciences

Several large investors have recently made changes to their positions in the stock. Pzena Investment Management LLC grew its position in USANA Health Sciences by 0.7% during the 1st quarter. Pzena Investment Management LLC now owns 1,095,186 shares of the company's stock worth $29,537,000 after acquiring an additional 8,110 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of USANA Health Sciences by 7.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock valued at $27,751,000 after buying an additional 55,059 shares during the last quarter. Pacer Advisors Inc. lifted its holdings in USANA Health Sciences by 8.8% during the 4th quarter. Pacer Advisors Inc. now owns 592,001 shares of the company's stock worth $21,247,000 after purchasing an additional 47,745 shares during the last quarter. Geode Capital Management LLC raised its holdings in USANA Health Sciences by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 301,949 shares of the company's stock valued at $10,839,000 after acquiring an additional 4,829 shares in the last quarter. Finally, American Century Companies Inc. increased its stake in shares of USANA Health Sciences by 9.2% in the 1st quarter. American Century Companies Inc. now owns 255,242 shares of the company's stock valued at $6,884,000 after purchasing an additional 21,445 shares during the last quarter. Institutional investors own 54.25% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Wall Street Zen raised USANA Health Sciences from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd. Sidoti lowered USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, February 18th. Finally, DA Davidson lowered their price objective on USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating on the stock in a research report on Thursday, February 27th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.